logo
calendar30 Dekabr 2019
view26
Main language:Uzbek

EXPRESSION OF CIRCULATING MICRORNA-AA IN CHRONIC VIRAL HEPATITIS AND THEIR SIGNIFICANCE

Field of Science:
pdf

5e09c82ece3f3.pdf

PDF

RE-HEALTH

RE-HEALTH

Publish Articlesee more

ARTICLE ANNOTATION

quote
MicroRNAs are short non-coding RNA molecules with a length of 19-23 nucleotides that regulate various physiological and pathophysiological processes. The aim of the study was to study the expression of microRNA-AA in chronic (HVGV and hvgs.) viral hepatitis. Materials and methods. The material for the study was blood plasma samples of 76 patients with chronic viral hepatitis and 30 healthy individuals. Results. The level of expression of microRNA-AA was significantly higher in HVGV and hvgs compared with the control group. Summary. Further study of microRNA-AA expression as promising non-invasive markers will determine the potential of these microRNAs as early predictors of liver fibrosis, liver cirrhosis and HCC.

AUTHORS

SH.Aliyev

TMA

A.Yusupov

TMA

N.Ibadullayeva

TMA

E.Zholdasova

НИИ Вирусологии МЗ РУз

Z.Juraeva

НИИ Вирусологии МЗ РУз

Tags

# expression# экспрессия# микроРНК-199а# СВГВ# СВГС# ХВГВ# ХВГС# microRNA-199a# microRNA-155# chronic HBV-infection# chronic HCV-infection

OTHER ARTICLES IN THIS JOURNAL

Rate Article

0
0 ratings
5
4
3
2
1

Article Identifiers

ROI:

https://eroi.uz/11.0082/A1219-0044

DOI:

Not Available

References

1. Шадрин В.О., Досенко В.Е. МикроРНК как диагностические биомаркеры поражения печени при Эпштейн–Барр вирусных гепатитах у детей.Современная педиатрия 1(65)/2015

2. Bala S., Tilahun Y., Taha O., Alao H., Kodys K., CatalanoD., Szabo G. Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection //J Transl Med. 2012. - Jul 30;10:151. doi: 10.1186/1479-5876-10-151.

3. Cermelli S. Circulating microRNAs in patients with chronic hepatitis C and non@alcoholic fatty liver disease / S. Cermelli, A. Ruggieri, J. A. Marrero // PLoS One 6. — 2011. — e23937. Gao B. and Bataller R. Alcoholic liver disease: pathogenesis and new the@ rapeutic targets / B. Gao // Gastroenterology. — 2011. — Vol. 141. —P. 1572—1585.

4. Chang C.C., Lin C.C., Hsieh W.L., Lai H.W., Tsai C.H.,Cheng Y.W. MicroRNA expression profiling in PBMCs: a potential diagnostic biomarker of chronic hepatitis C //Dis Markers. 2014;2014:367157. doi: 10.1155/2014/367157. Epub 2014 Nov 18.

5. Circulating microRNAs in exosomes indicate hepatocyte injuryand inflammation in alcoholic, drug@induced, and inflammatory liver dis@eases / Bala S., Petrasek J., Mundkur S. [et al.] // Hepatology. —2012. — Vol. 56. — P. 1946—1957.

6. Circulating microRNAs: molecular microsensors in gastrointestinal can@cer / Blanco@Calvo M., Calvo L., Figueroa A. [et al.] // Sensors (Basel). —2012. — Vol. 12. — P. 9349—9362

7. Conrad K.D., Niepmann M. The role of microRNAs in hepatitisC virus RNA replication //Arch Virol. – 2014. – May 159(5). -P.849-862.

8. Gang Li., Guohong Cai., Demin Li., Wen Yin. MicroRNAs and liver disease: viral hepatitis, liver fibrosis and hepatocellular carcinoma //Postgrad Med J. -2014. - 90. - P.106-112.

9. Ge J, Huang Z., Liu H, Chen J., Xie Z. et al. Lower Expression of MicroRNA-155 Contributes to Dysfunction of Natural Killer Cells in Patients with Chronic Hepatitis B //Front Immunol. 2017.- Sep;22;8:1173. doi:10.3389/fimmu. 2017.01173. eCollection 2017.

10. Genomewide microRNA down@regulation as a negative feedback mechanism in the early phases of liver regeneration / Shu J., Kren B. T., Xia Z. [et al.] // Hepatology. — 2011. — Vol. 54. — P. 609—619.

11. Genomewide microRNA down@regulation as a negative feedback mechanism in the early phases of liver regeneration / Shu J., Kren B. T., Xia Z. [et al.] // Hepatology. — 2011. — Vol. 54. — P. 609—619.

12. Jennifer Louten., Michael Beach., Kristina Palermino., Maria Weeks., Gabrielle Holenstein. MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations //Biomarker Insights. – 2015. - 10(S4). - P.25-52.

13. MicroRNA profiling reveals a role for miR@29 in human and murine liver fibrosis / Roderburg C., Urban G. W., Bettermann K. [et al.]// Hepatolo@ gy. — 2011. — Vol. 53. — P. 209—218.

14. MicroRNA@21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer / Meng F., Henson R., Wehbe@Janek H. [et al.] // Gastroenterology. — 2007. — Vol. 133. — P. 647—658.

15. Qiu Z., Dai Y. Roadmap of miR-122-related clinical application from bench to bedside //Expert Opin Investig Drugs. - 2014.-Mar. 23(3). P.347-355.

16. Song G., Jia H., Xu H., Liu W. et al. Studying the association of microRNA-210 level with chronic hepatitis B progression //J Viral Hepat. - 2014. - Apr. 21(4). P.272-280.